A Quality by Design (QbD) Project of Human Dermal Fibroblast and its Therapeutic Effects on Managing Degenerative Intervertebral Disc Fibrosis in Rabbit and Cynomolgus Monkey
Li Zhou(Regend Therapeutics (China)), Shenao Zhou(Regend Therapeutics (China)), Ming Fan(Regend Therapeutics (China)), An Qin(Shanghai Ninth People's Hospital), Zhang Guicheng(Regend Therapeutics (China)), Lei Shi(Soochow University), Qin Zhang(Regend Therapeutics (China)), Hongsheng Li(Guangzhou Medical University Cancer Hospital), Jie Zhao(Shanghai Jiao Tong University), Hao Yang(Regend Therapeutics (China)), Chen Chen(Chongqing University), T. Y. Xing(Shanghai Jiao Tong University)
Cited by 5
Related Papers
Mesenchymal stem cells deliver exogenous miR‐21 <i>via</i> exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration
|Journal of Cellular and Molecular Medicine|2017|316
Circular RNA VMA21 protects against intervertebral disc degeneration through targeting miR-200c and X linked inhibitor-of-apoptosis protein
|Annals of the Rheumatic Diseases|2018|286
Inhibition of MDA-MB-231 breast cancer cell migration and invasion activity by andrographolide via suppression of nuclear factor-κB-dependent matrix metalloproteinase-9 expression
|Molecular Medicine Reports|2014|50
DNA framework-engineered chimeras platform enables selectively targeted protein degradation
|Nature Communications|2023|50